Tal Grenader
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- PARP inhibition in cancer therapy
- Dermatology top 5%
Papers in
- Oncology 25
- Inflammatory Biomarkers in Disease Prognosis 7
- Colorectal Cancer Treatments and Studies 5
- Lung Cancer Research Studies 3
- Co-authors
- Linda Shavit (26 shared papers)Alberto Gabizón (13 shared papers)Hilary Shmeeda (3 shared papers)John Bridgewater (6 shared papers)Tamar Peretz (6 shared papers)Stephen Nash (3 shared papers)Meyer D. Lifschitz (4 shared papers)Clare Peckitt (1 shared paper)
- Journals
- Anti-Cancer Drugs (8 papers)European Journal of Internal Medicine (3 papers)Annals of Oncology (3 papers)The Annals of Thoracic Surgery (2 papers)The Breast Journal (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Tal Grenader
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 87
- Oncology 424
- Dermatology 70
- Biomaterials 108
- Reproductive Medicine 60
- Pulmonary and Respiratory Medicine 161
Countries citing papers authored by Tal Grenader
This map shows the geographic impact of Tal Grenader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Grenader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Grenader more than expected).
Fields of papers citing papers by Tal Grenader
This network shows the impact of papers produced by Tal Grenader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Grenader. The network helps show where Tal Grenader may publish in the future.
Co-authors
The 25 scholars most cited alongside Tal Grenader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 100 | |
| 2 | 2016 | 83 | |
| 3 | 2011 | 76 | |
| 4 | 2016 | 58 | |
| 5 | 2015 | 57 | |
| 6 | 2017 | 57 | |
| 7 | 2015 | 53 | |
| 8 | 2017 | 40 | |
| 9 | 2012 | 39 | |
| 10 | 2007 | 30 | |
| 11 | 2014 | 29 | |
| 12 | 2008 | 28 | |
| 13 | 2017 | 27 | |
| 14 | 2011 | 25 | |
| 15 | 2012 | 22 | |
| 16 | 2008 | 21 | |
| 17 | Aortic occlusion in patients treated with Cisplatin-based chemotherapy. | 2006 | 21 |
| 18 | 2005 | 20 | |
| 19 | 2003 | 18 | |
| 20 | 2013 | 16 |
About Tal Grenader
Tal Grenader is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine and Genetics, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Alzheimer's disease research and treatments (5 papers), Male Breast Health Studies (4 papers), BRCA gene mutations in cancer (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Cardiac tumors and thrombi (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (424 citations), Dermatology (70 citations), Biomaterials (108 citations), Reproductive Medicine (60 citations) and Pulmonary and Respiratory Medicine (161 citations). Tal Grenader has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Linda Shavit, Alberto Gabizón, Hilary Shmeeda, John Bridgewater, Tamar Peretz, Stephen Nash, Meyer D. Lifschitz, Clare Peckitt, David Cunningham and J. Oates. Their work appears in journals such as Anti-Cancer Drugs, European Journal of Internal Medicine, Annals of Oncology, The Annals of Thoracic Surgery and The Breast Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.